Alpine Immune Sciences, Inc. (ALPN) Stock Overview
Explore Alpine Immune Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Alpine Immune Sciences, Inc. (ALPN)
Key Financials
Key Financials
Market Cap
4.5B
P/E Ratio
-100.94
EPS (TTM)
$-0.64
ROE
-0.13%
ALPN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Alpine Immune Sciences, Inc. (ALPN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $90.40.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -100.94 and a market capitalization of 4.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.